GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

T-A2-5

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act3113T-A2-5Staphylococcus aureusMIC (µg/ml)0.2 ~ 0.8No. of tested strains (5)10.7164/antibiotics.31.170
act3118T-A2-5S. epidermidisMIC (µg/ml)0.2 ~ 0.8No. of tested strains (4)10.7164/antibiotics.31.170
act3123T-A2-5Streptococcus pyogenesMIC (µg/ml)0.006 ~ 0.05No. of tested strains (7)10.7164/antibiotics.31.170
act3128T-A2-5S. pneumoniaeMIC (µg/ml)0.05 ~ 0.1No. of tested strains (6)10.7164/antibiotics.31.170
act3133T-A2-5S. faecalisMIC (µg/ml)0.1 ~ 0.4No. of tested strains (5)10.7164/antibiotics.31.170
act3138T-A2-5S. mitisMIC (µg/ml)0.025No. of tested strains (1)10.7164/antibiotics.31.170
act3143T-A2-5S. salivariusMIC (µg/ml)0.05No. of tested strains (1)10.7164/antibiotics.31.170
act3148T-A2-5S. sanguisMIC (µg/ml)0.05No. of tested strains (1)10.7164/antibiotics.31.170
act3153T-A2-5S. bovisMIC (µg/ml)0.4No. of tested strains (1)10.7164/antibiotics.31.170
act3158T-A2-5S. agalactiaeMIC (µg/ml)0.1No. of tested strains (1)10.7164/antibiotics.31.170
act3163T-A2-5S. pneumoniae L 44ED50 (mg/kg/day) sc0.1310.7164/antibiotics.31.170
act3168T-A2-5S. pyogenes L 49ED50 (mg/kg/day) sc0.1010.7164/antibiotics.31.170
act3173T-A2-5Acute toxicity in miceLD50 (mg/kg)500 ~ 1,00010.7164/antibiotics.31.170